
Precisio Biotix Therapeutics, Inc. is a U.S.-based biotechnology company developing targeted antimicrobial medicines for difficult-to-treat bacterial infections. Its engineered lysins are designed to selectively destroy harmful bacteria, including antibiotic-resistant bacteria and bacteria protected within biofilms, while overcoming key limitations of conventional antibiotics.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/23/26 | undisclosed |
Gates Foundation | undisclosed |